High-Density—Lipoprotein Cholesterol in Bodybuilders v Powerlifters: Title and subTitle BreakNegative Effects of Androgen Use FREE

Ben F. Hurley, PhD; Douglas R. Seals, PhD; James M. Hagberg, PhD; Ann C. Goldberg, MD; Steve M. Ostrove, MA; John O. Holloszy, MD; Walter G. Wiest, PhD; Andrew P. Goldberg, MD

[+] Author Affiliations

Reprint requests to Metabolism Section, Gerontology Research Center, Francis Scott Key Medical Center, 4940 Eastern Ave, Baltimore, MD 21224 (Dr A. P. Goldberg).

JAMA. 1984;252(4):507-513. doi:10.1001/jama.1984.03350040037019

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

To determine the relationship between lipid profiles and the type of weight training and to assess the effects of anabolic-androgenic steroids on lipids, bodybuilders and powerlifters of similar age, body fat, and testosterone levels were studied before and after androgen use. Before androgen administration powerlifters had lower levels of plasma high-density—lipoprotein cholesterol (HDL-C) and HDL₂-C (38±2; 6±1 mg/dL; X ± SE, n=8) than bodybuilders (55 ±2; 12 ± 1 mg/dL; n=8) and runners of comparable age and body fat (47 ±2; 14±2 mg/dL; n=8), while levels of low-density—lipoprotein cholesterol (LDL-C) were higher in powerlifters 138±10 mg/dL) than in bodybuilders (104±7 mg/dL) and runners (110 ±6 mg/dL). Therefore, powerlifters had higher LDL-C/HDL-C ratios (3.7 ±0.3) than bodybuilders (2.0 ±0.2) and runners (2.4 ±0.2). Androgen use by eight bodybuilders and four powerlifters lowered values of both HDL-C and HDL₂-C by 55% and raised values of LDL-C (61% ±10%) and LDL-C/HDL-C ratios (280%±40%). Therefore, the training regimen of bodybuilders is associated with a more favorable lipid profile than the training used by powerlifters. Androgen use by strength-trained athletes may increase their risk for coronary heart disease.

(JAMA 1984;252:507-513)

REFERENCES

ABSTRACT | REFERENCES

Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham Study . Ann Intern Med 1979;;90:85-91.

Castelli WP, Doyle JI, Gordon T, et al: HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study . Circulation 1977;;55:767-772.

Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease . JAMA 1984;;251:351-364.

Heath GW, Ehsani AA, Hagberg JM, et al: Exercise training improves lipoprotein lipid profiles in patients with coronary artery disease . Am Heart J 1983;;105:889-895.

Goldberg AP, Hagberg J, Delmez JA, et al: The metabolic and psychological effects of exercise training in hemodialysis patients . Am J Clin Nutr 1980;;33:1620-1628.

Wood PD, Haskell WL, Klein H, et al: The distribution of plasma lipoproteins in middle-aged male runners . Metabolism 1976;;25:1249-1257.

Berg A, Ringwald G, Keul J: Lipoprotein-cholesterol in well-trained athletes: A preliminary communication: Reduced HDL-cholesterol in power athletes . Int J Sports Med 1980;;1:137-138.

Clarkson PM, Hintermister R, Fillyaw M, et al: High density lipoprotein cholesterol in young adult weight lifters, runners, and untrained subjects . Hum Biol 1981;;53:251-257.

Farrell PA, Maksud MG, Pollock ML, et al: A comparison of plasma cholesterol, triglycerides, and high density lipoprotein-cholesterol in speed skaters, weightlifters and nonathletes . Eur J Appl Physiol 1982;;48:77-82.

Taggart HM, Applebaum-Bowden D, Haffner S, et al: Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis . Metabolism 1982;;31:1147-1152.

The Lipid Research Clinics Epidemiology Committee: Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study . Circulation 1979;;60:427-439.

Hartung HG, Foreyt JP, Mitchell RE, et al: Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men . N Engl J Med 1980;; 302:357-361.

Brozek J, Grande F, Anderson J, et al: Densitometric analysis of body composition: Revision of some quantitative assumptions . Ann NY Acad Sci 1963;;110:113-140.

Wilmore J, Bodak PA, Parr RB, et al: Further simplification of a method for determination of residual lung volume . Med Sci Sports Exer 1980;;12:216-218.

Lipid Research Clinics Program : Manual of Laboratory Operations: Lipid and Lipoprotein Analysis . National Heart and Lung Institute, US Dept of Health, Education, and Welfare publication (NIH) 75-628. Bethesda, Md, National Institutes of Health, 1974;.

Gidez LI, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure . J Lipid Res 1982;;23:1206-1223.

Wiest WG, Paulson JD, Keller DW, et al: Free testosterone concentration in serum: A method for determination . Am J Obstet Gynecol 1978;;130:321-328.

Herbert V, Lau KS, Gottlieb GW, et al: Coated charcoal immuno-assay of insulin . J Clin Endocrinol Metabol 1965;;25:1375-1384.

Miller NE: HDL cholesterol, tissue cholesterol and coronary atherosclerosis: Epidemiological correlations , in Sotto AM, Smith LC, Allen B (eds): Atherosclerosis V . New York, Springer-Verlag, 1980;, pp 500-503.

Haffner SM, Kushwaha RS, Foster DM, et al: Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy . Metabolism 1983;;32:413-420.

Kuusi T, Saarinen P, Nikkila EA: Evidence for the role of hepatic endothelial lipase on the metabolism of plasma high density lipoproteins in man . Atherosclerosis 1980;;36:589-593.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal